U.S.-based Carlyle Group Inc has agreed to buy a 20-percent stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for about 490 million U.S. dollars, the companies said i
CGTN
Showing 0 to 17 of 1 results